BrightSpring Q3 revenue up 28% to $3.33B; net income $37.5M; raises FY guidance

BrightSpring Health Services, Inc.

2025-Q3 EPS reported $0.52 revenue$9,359,933,000

Revenue $3,334M (+28.2% YoY); net income $37.5M vs loss $25.7M in Q3 2024.
Adjusted EBITDA $160M (+37.2% YoY); FY 2025 guidance reiterated at $605-615M.
FY revenue guidance raised to $12.5-12.8B (24-27% growth); Pharmacy segment guidance $11.05-11.3B.
Planned Community Living divestiture to Sevita on track for Q1 2026; 15M-share secondary offering closed Oct 22.
Leverage 3.31x; Pharmacy segment EBITDA $141M (+42%), Provider segment EBITDA $61M (+16%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.